Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02039544Unknown
Randomised, double-blind trial in diabetic peripheral neuropathy (DPN) comparing Xuebi formula with Placebo (2 arms). Primary endpoints: Toronto Clinical Scoring System at 24 weeks and Traditional Chinese Medicine clinical symptom score at 24 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02039544.